Life Sciences Times

Sumitomo Pharma’s Enzomenib Receives FDA Orphan Drug Designation for Acute Lymphoblastic Leukemia

Bicycle Therapeutics Narrows Second-Quarter Loss, Extends Cash Runway Into 2030

Alnylam Reports 74% Revenue Growth in Second Quarter, Lowers 2026 TTR Outlook

Wolters Kluwer, Epic Expand Clinical Information Access for Rural and Underserved Providers

Sail Biomedicines, Johnson & Johnson Partner on In Vivo CAR-T Therapies

Iksuda Receives FDA IND Clearance for IKS04 in Gastrointestinal Cancers

Boston Scientific Reports 7.5% Increase in Second-Quarter Sales

WHOOP Appoints Kyle Leahy as Chief Commercial Officer

QT Imaging Appoints Julia Albright, Ph.D., as Chief Science Officer

Adjuvia Therapeutics Raises $8 Million to Advance Mitochondrial Disease Drug